Comprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structures

dc.contributor.authorĐurendić, Evgenijaen_US
dc.contributor.authorAjduković, Jovanaen_US
dc.contributor.authorJevrić, Lidijaen_US
dc.contributor.authorJovanov, Pavleen_US
dc.contributor.authorKovačević, Strahinjaen_US
dc.contributor.authorPodunavac-Kuzmanović, Sanjaen_US
dc.date.accessioned2017-11-27T15:05:12Z
dc.date.available2017-11-27T15:05:12Z
dc.date.issued2016-10-10
dc.descriptionpeer-revieweden_US
dc.description.abstractThe selection of the most promising anticancer compounds from the pool of the huge number of synthesized molecules is a quite complex task. There are many compounds characterization approaches which can suggest the best structural features of a molecule with the highest antiproliferative effect on the certain type of cancer cell lines. One of these approaches is the lipophilicity determination of compounds and the analysis of its correlation with the anticancer activity. Since the importance of the lipophilicity is underlined in many earlier studies, this study is focused on determination of lipophilicity of previously synthesized 17α-picolyl and 17(E)-picolinylidene androstane derivatives by using reversed-phase high performance liquid chromatography (RP-HPLC) as a very fast, effective and relatively cheap method. Determination of the chromatographic lipophilicity of the studied androstanes can be considered as the part of their physicochemical characterization, which is a very important step in their further selection as drug candidates. The present study does not neglect the in silico approach. The determined chromatographic lipophilicity was analyzed by quantitative structure-retention relationship (QSRR) approach in order to reveal which molecular characteristics contribute mostly to the typical behavior of the androstanes in the applied chromatographic system, and thus to their lipophilicity. Classical statistical approach and Sum of Ranking Differences method were used for selection of the best QSRR models which should be used in prediction of chromatographic lipophilicity of studied androstane derivatives.en_US
dc.description.sponsorshipThis study is financially supported by the research projects of the Ministry of Education, Science and Technological Development of the Republic of Serbia (No. 172012 and No. 172021) and the research project of the Provincial Secretariat for Science and Technological Development of Vojvodina (No. 114-451-347/2015-02).en_US
dc.identifier.citationS. Kovačević, S. Podunavac-Kuzmanović, L. Jevrić, P. Jovanov, E. Đurendić, J. Ajduković. Comprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structures. European Journal of Pharmaceutical Sciences, 93 (2016) 1–10. DOI: 10.1016/j.ejps.2016.07.008en_US
dc.identifier.issn0928-0987
dc.identifier.urihttp://oa.fins.uns.ac.rs/handle/123456789/39
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172021/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172012/RS//
dc.relation.ispartofseries001;0034
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectandrostane derivativesen_US
dc.subjectanticancer compoundsen_US
dc.subjectchemometricsen_US
dc.subjectlipophilicityen_US
dc.subjectmolecular modelingen_US
dc.subjectreversed-phase HPLCen_US
dc.titleComprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structuresen_US
dc.title.alternative-en_US
dc.typeinfo:eu-repo/semantics/articleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Kovacevic et al. 2016 final.pdf
Size:
1.8 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
19.5 KB
Format:
Item-specific license agreed upon to submission
Description: